Inventor · disambiguated record
Hirofumi Tachibana
Also filed as: TACHIBANA HIROFUMI
7 granted patents·13 pending applications·103 citations·filing 1997–2024
83Inventor score
Files withUNIV KYUSHU NAT UNIV CORP5TACHIBANA HIROFUMI4NAT AGRICULTURAL RES ORG3JUJO PAPER CO LTD2NAKASONE AKARI2
Top patents by PatentIndex Score
20 records- 0182US5889323ASemiconductor package and method of manufacturing the sameNEC CORP·Filed 1997·Granted Mar 30, 1999·82 cites·2 claims
- 0277US10251408B2Catechin function enhancement methodUNIV KYUSHU NAT UNIV CORP·Filed 2015·Granted Apr 9, 2019·3 cites·7 claims
- 0377US6491943B2Method for treating an allergic or inflammatory diseaseNAT AGRICULTURAL RES ORG·Filed 2001·Granted Dec 10, 2002·10 cites·5 claims
- 0471US6638524B2Cosmetics, foods and beverages supplemented with purified strictininNAT AGRICULTURAL RES ORG·Filed 2002·Granted Oct 28, 2003·5 cites·28 claims
- 0567US6899893B2Method for treating an allergic or inflammatory diseaseNAT AGRICULTURAL RES ORG·Filed 2003·Granted May 31, 2005·3 cites·15 claims
- 0666US12186302B2Dipeptidyl peptidase-IV inhibitor and food with function claimsNAKASONE AKARI·Filed 2021·Granted Jan 7, 2025·0 cites·2 claims
- 0761US2024325544A1Cationic lipid for covalent modification of peptidesPHARMALN CORP·Filed 2024·Application pending·0 cites
- 0860US2025152552A1Cancer-cell proliferation inhibitor and cancer-cell-proliferation inhibition enhancerUNIV KYUSHU NAT UNIV CORP·Filed 2022·Application pending·0 cites
- 0949US7736856B2Method of screening drug with the use of 67 kDa laminin receptor and drug obtained therebyKYUSHU TLO CO LTD·Filed 2004·Granted Jun 15, 2010·0 cites·6 claims
- 1049US2023241164A1C-Type Natriuretic Peptides and Methods Thereof in Treating CancerTACHIBANA HIROFUMI·Filed 2021·Application pending·0 cites
- 1149US2023416328A1C-Type Natriuretic Peptides and Methods Thereof in Treating Acute Lung InjuryTACHIBANA HIROFUMI·Filed 2021·Application pending·0 cites
- 1245US2020230100A1Agonist of 67 kda laminin receptor and utilization thereofUNIV KYUSHU NAT UNIV CORP·Filed 2017·Application pending·0 cites
- 1345US2023233518A1Catechin containing compositions and usesADAMAS BIOTECH S R L·Filed 2021·Application pending·0 cites
- 1443US2008262080A1Allergy Suppressive AgentUNIV KYUSHU NAT UNIV CORP·Filed 2005·Application pending·0 cites
- 1543US2023092815A1Composition and functional food product comprising green tea extractNAKASONE AKARI·Filed 2021·Application pending·0 cites
- 1643US2013172356A1Combination of egcg or methylated egcg and a pde inhibitorTACHIBANA HIROFUMI·Filed 2011·Application pending·0 cites
- 1740US2016000750A1Combination of egcg or methylated egcg and a pde inhibitorUNIV KYUSHU NAT UNIV CORP·Filed 2015·Application pending·0 cites
- 1840US2010222424A1Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained TherebyTACHIBANA HIROFUMI·Filed 2010·Application pending·0 cites
- 1934US2018271927A1Brain function-protecting agentJUJO PAPER CO LTD·Filed 2016·Application pending·0 cites
- 2025US2017182110A1Agent for preventing or ameliorating diabetesJUJO PAPER CO LTD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →